Roche and CuraGen have announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in ...

'This hybrid sequencing strategy has the potential for being the first in years to have a major impact on the sequencing community,' the authors write. Indeed, they estimate the hybrid approach can ...

454 Life Sciences Corporation, in collaboration with scientists at the Human Genome Sequencing Center, Baylor College of Medicine, has announced in Houston, Texas, the completion of a project to ...

In the past two years, methods to sequence DNA faster and cheaper gave scientists the ability to "bring sequencing back into the lab," says Neil Hall, professor of Genomics at the University of ...

Genotypic testing is recommended as the preferred resistance testing method to guide therapy in antiretroviral-naive and antiretroviral-experienced persons. A major limitation of clinically available ...